Perth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) attaches a copy of a recent news release by MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) (OTCMKTS:MLCPF) announcing management team changes.
MMJ owns approximately 4.4 million shares for a 4.3% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
To view the news release, please visit:
http://abnnewswire.net/lnk/2Y275520
MMJ owns approximately 4.4 million shares for a 4.3% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
To view the news release, please visit:
http://abnnewswire.net/lnk/2Y275520
About MMJ Group Holdings Ltd:
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/
Source:
MMJ Group Holdings Ltd
Contact:
Investor and Media Enquiries: Jason Conroy Chief Executive Officer T: +61-2-8098-0819 E: info@mmjgh.com.au